FDA CDER Drug Review and Approval Tools (Pre-Market) — US Federal IT Dashboard CIO ratings — Tollgate Data

FDA CDER Drug Review and Approval Tools (Pre-Market)FDA CDER Drug Review and Approval Tools (Pre-Market) (Department of Health and Human Services) appears in one US IT Dashboard snapshot, 2024-06-30.Its latest rating is Moderately Low Risk (2024-06-30).

Snapshot

Cost

Planned finish

Rating

2024-06-30

Moderately Low Risk

Cite: General Services Administration (for OMB's IT Dashboard) (2026). US Federal IT Dashboard CIO ratings: FDA CDER Drug Review and Approval Tools (Pre-Market). Tollgate Data, https://data.tollgatehq.com/projects/us-itdb/5fd902c3c885704b4c702856, as at 7 Sep 2026. Licence: US public domain.QuestionsWhat is FDA CDER Drug Review and Approval Tools (Pre-Market)'s latest rating? Its latest rating is Moderately Low Risk (2024-06-30).US Federal IT Dashboard CIO ratingsUS Federal IT Dashboard CIO ratings projects